Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Now accepting nominations for the Fierce Innovation Awards - Submit your application today
Foundayo
Pharma
Eli Lilly's Zepbound preferred by physicians: Spherix survey
A Spherix survey of physicians shows that injected weight loss drugs remain favored over newer oral treatments, with Lilly’s Zepbound leading the pack
Kevin Dunleavy
Aug 7, 2026 11:36am
The Oral GLP-1 Tracker: Lilly's Foundayo builds scripts
Aug 7, 2026 10:45am
Amid struggles of Lilly's Foundayo, injectables still on a roll
Aug 5, 2026 11:42am
In Europe, Lilly exec says MFN will affect Foundayo launch
Jun 24, 2026 11:20am
'Familiarity' with oral Wegovy has triggered its quick uptake
Jun 18, 2026 11:15am
ADA: Lilly's Foundayo pads case against semaglutide in diabetes
Jun 8, 2026 3:42pm
